July 2010

In response to the National Institutes of Health (NIH) call for comments regarding proposed transparency rules, the Association…

An interesting video and script from MedScape recently discussed a troubling trend in clinical research regarding gastrointestinal…

After an FDA external advisory panel last week provided mixed recommendations regarding Avandia (rosiglitazone), the American…

According to the Global Education Group, the ACCME 2009 annual report data showed that “increased competition for continuing…

The Boston Globe reported that “pharmaceutical giant Merck & Co., will shut a five-year-old Cambridge research lab as part of…

Last week, the Food and Drug Administration (FDA) imposed a Risk Evaluation and Mitigation Strategy (REMS) on AR Scientific…

The Boston Business Journal recently highlighted the “Collaboration Gap” that is being caused by the gift ban in Massachusetts,…

As drug companies “prepare for new draconian provisions for reporting on financial relationships with academia,” a recent article…

Physicians at the University of Wisconsin-Madison Medical School are no longer taking lightly the recently drafted foundation…

The FDA advisory panel on Avandia voted in favor of keeping Avandia (rosiglitizone) on the market the vote breaks down as…